Can-Fite BioPharma Ltd. (CANF) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$405.0K

Net Income/Loss (FY2025)

-$9.8M

Total Assets (FY2025)

$9.5M

Total Equity (FY2025)

$5.6M

Cash Flows from Operating Activities (FY2025)

-$8.9M

Source: Can-Fite BioPharma Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.